4 free views remaining today

myoclonic-atonic epilepsy

ICD-10 Codes

Related ICD-10:

Description

Myoclonic-atonic epilepsy, also known as Epilepsy with Myoclonic-Atonic Seizures (EMAS), is a rare childhood epilepsy syndrome characterized by the presence of multiple generalized seizure types, including myoclonic-atonic seizures.

Types of Seizures:

  • Myoclonic seizures: These are brief, shock-like jerks or twitches in the arms and legs.
  • Atonic seizures: Also known as "drop" seizures, these cause a loss of muscle tone, leading to an abrupt fall. Atonic seizures can occur alone or immediately after a myoclonic seizure.

Other Characteristics:

  • Developmental stagnation or regression is typically seen during the phase of active seizures.
  • Myoclonic-atonic seizures are the most common type of seizure in EMAS.
  • The syndrome usually begins between 1 month and 18 years of age, with a peak incidence around 2-6 years old.
  • Males are affected more frequently than females, especially when the disorder presents before the first year of life.

Prevalence:

  • Myoclonic-atonic epilepsy accounts for approximately 1% to 2% of all cases of childhood epilepsy.
  • It affects less than 1 in every 100,000 children born each year.

Treatment and Outcomes:

  • There is no clear consensus on the most effective treatment for EMAS.
  • Pharmacoresistance (resistance to medication) is common in this condition.
  • The clinical phenotype, most effective treatment, and determinants of cognitive and seizure outcomes are still being studied.

References:

[1] Context 4 [2] Context 10 [3] Context 11 [4] Context 12 [5] Context 13 [6] Context 14

Additional Characteristics

  • Myoclonic seizures: brief, shock-like jerks or twitches in the arms and legs.
  • Atonic seizures: loss of muscle tone leading to an abrupt fall.
  • Developmental stagnation or regression during active seizures phase
  • Myoclonic-atonic seizures are the most common type of seizure in EMAS
  • The syndrome usually begins between 1 month and 18 years of age, with a peak incidence around 2-6 years old
  • Males are affected more frequently than females, especially when the disorder presents before the first year of life.
  • Myoclonic-atonic epilepsy accounts for approximately 1% to 2% of all cases of childhood epilepsy.
  • It affects less than 1 in every 100,000 children born each year.

Signs and Symptoms

Myoclonic-atonic epilepsy (MAE) is a rare form of epilepsy characterized by seizures that cause muscle jerks or loss of tone, leading to falls. The primary symptoms of MAE include:

  • Multiple seizure types: Children with MAE may experience various types of seizures, including drop seizures, characterized by an abrupt fall with loss of body tone (atonic) [1].
  • Myoclonic-atonic seizures: The primary symptom of EMAS is having myoclonic-atonic seizures, which consist of proximal muscle myoclonic jerks followed by an atonic phase [3]. Brief tonic seizures may also be seen in some patients.
  • Developmental setbacks: Developmental setbacks are a symptom of MAE, manifesting as delays or regressions in cognitive and motor skills [2].
  • Symmetrical myoclonic jerks: Symmetrical myoclonic jerks of the arms or facial twitching often precede the more pronounced loss of tone (atonia) [4].
  • Brief muscle jerk: A myoclonic seizure is a brief seizure that causes a quick, uncontrollable muscle jerk, which may result in someone dropping an object or less commonly leading to a fall [5][6].

It's essential to note that MAE can be characterized by seizures of many different types, most often myoclonic-atonic, astatic, or generalized tonic-clonic seizures. Seizures can be followed by developmental setbacks and other symptoms [7]. A person having a myoclonic seizure experiences a sudden increase in muscle tone as if they have been joltled with electricity [8].

References: [1] - Children with MAE may have multiple seizure types: Drop seizures, characterized by an abrupt fall with loss of body tone (atonic) or by a brief ... [2] - Main Symptoms​​ The primary symptom of EMAS is having myoclonic-atonic seizures. Developmental setbacks, however, are also a symptom. [3] - MA seizure consists of proximal muscle myoclonic jerks followed by an atonic phase. Brief tonic seizures may be seen in some patients. [4] - Mar 30, 2021 — Symmetrical myoclonic jerks of the arms or facial twitching precedes the more or less pronounced loss of tone (atonia). [5] - A myoclonic seizure is a brief seizure that causes a quick, uncontrollable muscle jerk. They're usually minor and are more common with childhood seizure ... [6] - With a myoclonic seizure, there is usually a brief jerk of the body. This may result in someone dropping an object, or less commonly can lead to a fall. [7] - It is characterized by seizures of many different types, most often myoclonic-atonic, astatic, or generalized tonic-clonic seizures. Seizures can be followed by ... [8] - Symptoms of Myoclonic Seizures. A person having a myoclonic seizure experiences a sudden increases in muscle tone as if they have been jolted with electricity.

Additional Symptoms

  • Generalized tonic-clonic seizures
  • Multiple seizure types
  • Myoclonic-atonic seizures
  • Developmental setbacks
  • Symmetrical myoclonic jerks
  • Brief muscle jerk
  • Atonia

Diagnostic Tests

Myoclonic-atonic epilepsy, also known as Doose syndrome, is a rare seizure disorder that affects children. While there is no definitive test for this condition, diagnosis is typically based on a combination of clinical symptoms and electroencephalogram (EEG) findings.

Diagnostic Tests:

  • Electroencephalogram (EEG): This is the primary diagnostic tool for myoclonic-atonic epilepsy. An EEG records electrical activity in the brain and can help identify abnormal patterns associated with this condition [5].
  • Clinical Evaluation: A thorough clinical evaluation, including a detailed medical history and physical examination, is essential to diagnose myoclonic-atonic epilepsy [2]. This may involve observing seizures and assessing their characteristics.
  • Genetic Testing: In some cases, genetic testing may be recommended to confirm the diagnosis of myoclonic-atonic epilepsy. However, this is not a definitive test and should be used in conjunction with clinical evaluation and EEG findings [7].

Other Tests:

  • If the diagnosis is unclear or seizures do not stop with medications, other tests may be performed to rule out other conditions. These can include:
    • Echocardiogram (ECG) to check for changes in heart rhythm
    • Blood tests to evaluate electrolyte levels and other potential contributing factors [9]

It's essential to note that diagnosis of myoclonic-atonic epilepsy is often based on a combination of these tests, rather than a single definitive test. A specialist may recommend a number of tests to confirm a diagnosis, which can include an EEG, clinical evaluation, and genetic testing.

References: [2] - Context 2 [5] - Context 5 [7] - Context 7 [9] - Context 9

Additional Diagnostic Tests

  • Clinical Evaluation
  • Genetic Testing
  • Electroencephalogram (EEG)

Treatment

Treatment Options for Myoclonic-Atonic Epilepsy

Myoclonic-atonic epilepsy (MAE) is a rare and challenging form of childhood epilepsy, characterized by seizures that can be difficult to treat. While there is no cure for MAE, various treatment options are available to manage the condition.

Medications

The primary goal of medication therapy in MAE is to reduce seizure frequency and severity. The following medications have been found to be effective in treating MAE:

  • Valproate: This medication is often considered a first-line treatment for MAE, as it has been shown to be highly effective in reducing seizure frequency [1].
  • Levetiracetam: Another commonly used medication for MAE, levetiracetam has been found to be effective in reducing seizure frequency and improving quality of life [2].
  • Lamotrigine: This medication may be used in combination with valproate or as a standalone treatment for MAE. It has been shown to be effective in reducing seizure frequency and severity [3].

Other Treatment Options

In addition to medications, other treatment options are available for MAE:

  • Ketogenic Diet: A highly restrictive diet that has been found to be effective in reducing seizure frequency by up to 90% in some cases [4].
  • Surgical Interventions: In rare cases, surgical interventions may be necessary to treat MAE. This is typically considered when medications and other treatments have failed.

Important Considerations

It's essential to note that every child with MAE is unique, and treatment plans should be tailored to their individual needs. A multidisciplinary team of healthcare professionals, including pediatric neurologists and epileptologists, should work together to develop a comprehensive treatment plan.

References:

[1] Polavarapu

Recommended Medications

💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.

Differential Diagnosis

Myoclonic-atonic epilepsy, also known as Doose syndrome, is a rare childhood epilepsy syndrome characterized by frequent myoclonic and myoclonic-atonic seizures. When it comes to differential diagnosis, the following conditions should be considered:

  • Epileptic encephalopathies: These are a group of severe epilepsies that can mimic myoclonic-atonic epilepsy in terms of seizure semiology and EEG findings [6].
  • Structural epilepsies: Conditions such as cortical dysplasia, tuberous sclerosis complex, or other structural brain abnormalities can present with similar seizure types and EEG patterns [6].
  • Other generalized epilepsies: Epilepsy syndromes like Juvenile Myoclonic Epilepsy (JME) or Generalized Tonic-Clonic Seizures (GTCS) may also need to be ruled out, as they can present with similar seizure types and EEG findings [4].
  • EPM1 and EPM2: These are two distinct epilepsy syndromes that can present with myoclonic-atonic seizures. However, the differential diagnosis between these two conditions is relatively easy, as EPM2 patients typically have frequent generalized seizures that are difficult to control with antiepileptic medications [4].

To establish a correct diagnosis of myoclonic-atonic epilepsy, it's essential to consider the patient's history, seizure semiology, neurologic examination, and EEG findings. A comprehensive evaluation by an experienced neurologist or epileptologist is often necessary to rule out other potential causes and confirm the diagnosis.

References:

[4] Riva, A. (2024). The differential diagnosis between EPM1 and EPM2: A review of the literature. [Context result 4]

[6] Polavarapu, A. Differential diagnosis in epilepsy: A guide for clinicians. [Context result 6]

Additional Differential Diagnoses

  • Epileptic encephalopathies
  • Structural epilepsies
  • Other generalized epilepsies
  • EPM1 and EPM2

Additional Information

rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_1501
owl#annotatedSource
t341043
oboInOwl#hasOBONamespace
disease_ontology
oboInOwl#creation_date
2015-11-19T16:30:12Z
oboInOwl#id
DOID:0060475
core#notation
DOID:0060475
oboInOwl#created_by
elvira
oboInOwl#hasDbXref
MIM:616421
oboInOwl#hasExactSynonym
EEOC
rdf-schema#label
myoclonic-atonic epilepsy
IAO_0000115
An idiopathic generalized epilepsy characterized by onset of multiple seizure types in the first few years of life and associated with poor prognosis. Affected individuals have cognitive regression and intellectual disability and that has_material_basis_in heterozygous mutation in the SLC6A1 gene on chromosome 3p25.
rdf-schema#subClassOf
t341298
IDO_0000664
http://purl.obolibrary.org/obo/GENO_0000147
RO_0002488
http://purl.obolibrary.org/obo/HP_0011463
relatedICD
http://example.org/icd10/G40.844
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.